Bioherent is a provider of diagnostic test for drug allergies.
Bioherent's investors include Bullnet Capital, Axon Partners Group, Centre for the Development of Industrial Technology (CDTI).
Bioherent is headquartered in Alhaurín De La Torre, Spain.
Bioherent is a provider of diagnostic test for drug allergies.
Bioherent is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Bioherent — Funding & Investors." VCBacked, July 17, 2025, https://www.vcbacked.co/company/bioherent. Accessed September 30, 2026.
VCBacked. (2025). Bioherent — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/bioherent
{{cite web |title=Bioherent — Funding & Investors |url=https://www.vcbacked.co/company/bioherent |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated